Predicting the structure of protein complexes: A step in the right direction

Chemistry and Biology

Volumn 3, Issue 3, 1996, Pages 151-156

  Shoichet, Brian K ^a   Kuntz, Irwin D ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CHEMICAL STRUCTURE; PROTEIN CONFORMATION; REVIEW;

ALGORITHMS; MODELS, MOLECULAR; PROTEIN CONFORMATION;

EID: 0030090466     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90256-2     Document Type: Short Survey

References (49)

1. Pauling, L. & Delbruck, M. (1940). The nature of the intermolecular forces operative in biological processes. Science 92, 77-79.
2. Connolly, M.L. (1986). Shape complementarity at the hemoglobin a1b1 subunit interface. Biopolymers 25, 1229-1247.
3. Crick, F.H.C. (1953). The packing of α-helices: simple coiled-coils. Acta. Crystallogr. 6, 689-697.
4. Wodak, S.J. & Janin, J. (1978). Computer analysis of protein-protein interaction. J. Mol. Biol. 124, 323-342.
5. Wodak, S.J., De Crombrugghe, M. & Janin, J. (1987). Computer studies of interactions between macromolecules. Prog. Biophys. Mol. Biol. 49, 29-63.
6. Shoichet, B.K. & Kuntz, I.D. (1991). Macromolecular docking. J. Mol. Biol. 221, 327-346.
7. Cherfils, J., Duquerroy, S. & Janin, J. (1991 ). Protein-protein recognition analysed by docking simulation. Proteins 11, 271-280.
8. Katchalski-Katzir, E., et al., & Vakser, I.A. (1992). Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad Sci. USA 89, 2195-2199.
9. Totrov, M. & Abagyan, R. (1994). Detailed ab initio prediction of lysozyme-antibody complex with 1.6 Å accuracy. Nature Struct. Biol. 1, 259-263.
10. Jiang, F. & Kim, S.H. (1991). "Soft docking": matching of molecular surface cubes. J. Mol. Biol. 201, 79-102.
11. Hart, T.N. & Read, R.J. (1992). A multiple start Monte-Carlo docking method. Proteins 13, 206-222.
12. Caflisch, A., Niederer, P. & Anliker, M. (1992). Monte-Carlo docking of oligopeptides to proteins. Proteins 13, 223-230.
13. Bacon, D.J. & Moult, J. (1992). Docking by least-squares fitting of molecular surface patterns. J. Mol. Biol. 225, 849-858.
14. Stoddard, B.L. & Koshland, D.E. (1992). Prediction of the structure of a receptor-protein complex using a binary docking method. Nature 358, 774-776.
15. Norel, R., Fischer, D., Wolfson, H.J. & Nussinov, R. (1994). Molecular surface recognition by a computer vision-based technique. Protein Eng. 7, 39-46.
16. Strynadka, N.C.J., et al., & James, M.N.G. (1996). Molecular docking programs successfully predict the binding of a β-lactamase inhibitory protein to TEM-1 β-lactamase. Nature Struct. Biol. 3, 233-239.
17. Goodsell, D.S. & Olson, A.J. (1990). Automated docking of substrates to proteins by simulated annealing. Proteins 8, 195-202.
18. Jackson, R.M. & Sternberg, M.J. (1995). A continuum model for protein-protein interactions: application to the docking problem. J. Mol. Biol. 250, 258-275.
19. Horton, N. & Lewis, M. (1992). Calculation of the free energy of association for protein complexes. Protein Sci. 1, 169-181.
20. Connolly, M.L. (1983). Solvent-accessible surfaces of proteins and nucleic acids. Science 221, 709-713.
21. Gilson, M.K. & Honig, B.H. (1987). Calculation of electrostatic potentials in an enzyme active site. Nature 330, 84-86.
22. Janin, J. (1996). Protein-protein recognition. Prog. Biophys. Mol. Biol., in press.
23. Strynadka, N.C., et al., & James, M.N. (1994). Structural and kinetic characterization of a β-lactamase-inhibitor protein. Nature 368, 657-660.
24. Janin, J. & Chothia, C. (1990). The structure of protein-protein recognition sites. J. Biol. Chem. 265, 16027-16030.
25. Shi, Y.Y., et al., & van Gunsteren, W.F. (1993). Can the stability of protein mutants be predicted by free energy calculations? Protein Eng. 6, 289-295.
26. Ponder, J.W. & Richards, F.M. (1987). Tertiary templates for proteins: use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193, 775-791.
27. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
28. Gehlhaar, D.K., et al., & Freer, S.T. (1995). De novo design of enzyme inhibitors by Monte-Carlo ligand generation. J. Med. Chem. 38, 466-472.
29. Cherfils, J., Bizebard, T., Knossow, M. & Janin., J. (1994). Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19. Proteins 18, 8-18.
30. von Itzstein, M., et al., & Penn, C.R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
31. Lam, P.Y.S., et al., & Erickson-Viitanen, S. (1994). Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263, 380-384.
32. Montgomery, J.A., et al., & Ealick, S.E. (1993). Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine. J. Med. Chem. 36, 55-69.
33. Appelt, K., et al., & White, J. (1991). Design of enzyme inhibitors using iterative protein crystallographic analysis. J. Med. Chem. 34, 1925-1934.
34. Bohm, H.-J. (1992). The computer program Ludi: a new method for the de novo design of enzyme inhibitors. J. Comput. Aided Mol. Des. 6, 61-78.
35. Goodford, P.J. (1985). A computational procedure for determining energetically favored binding sites on biologically important macromolecules. J. Med. Chem. 28, 849-857.
36. Kuyper, L.F., et al., & Stables, J.N. (1996). High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. J. Med. Chem. 39, 892-903.
37. Straatsma, T.P. & McCammon, J.A. (1991). Theoretical calculations of relative affinities of binding. Methods Enzymol. 202, 497-511.
38. Moon, J.B. & Howe, W.J. (1991). Computer design of bioactive molecules: a method for receptor-based de novo ligand design. Proteins 11, 314-328.
39. Miranker, A. & Karplus, M. (1991). Functionality maps of binding sites: a multicopy simultaneous search method. Proteins 11, 29-34.
40. Lewis, R.A., et al., & Kuntz, I.D. (1992). Automated site-directed drug design using molecular lattices. J. Mol. Graph. 10, 66-78.
41. Bohacek, R.S. & McMarty, C. (1994). Multiple highly diverse structures complementary to enzyme binding sites: results of extensive application of a de novo design method incorporating combinatorial growth. J. Am. Chem. Soc. 116, 5560-5571.
42. Bartlett, P.A., Shea, G.T., Telfer, S.T. & Waterman, S. (1989). CAVEAT: a program to facilitate the structure-derived design of biologically active molecules. In Molecular Recognition. (Roberts, S.M., ed.), pp. 182-196, Royal Society of Chemistry, London.
43. Lawrence, M.C. & Davis, P.C. (1992). CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure. Proteins 12, 31-41.
44. DesJarlais, R.L., et al., & Craik, C.S. (1990). Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc. Natl. Acad. Sci. USA 87, 6644-6648.
45. Mattos, C., et al., & Ringe, D. (1994). Analogous inhibitors of elastase do not always bind analogously. Nature Struct. Biol. 1, 55-58.
46. Shoichet, B.K., Perry, K.M., Santi, D.V., Stroud, R.M. & Kuntz, I.D. (1993). Structure-based discovery of inhibitors of thymidylate synthase. Science 259, 1445-1450.
47. Rutenber, E., et al., & Stroud, R.M. (1993). Structure of a non-peptide inhibitor complexed with HIV-1 protease. J. Biol. Chem. 268, 15343-15346.
48. Bodian, D.L., et al., & Kuntz, I.D. (1993). Inhibition of the fusion-inducing conformational change of the influenza hemagglutinin by bensoquinones and hydroquinones. Biochemistry 32, 2967-2978.
49. Ring, C.S., et al., & Cohen, F.E. (1993). Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc. Natl. Acad. Sci. USA 90, 3583-3587.